Clinical Trial: Efficacy and Safety of Nerivio for the Management of Amplified Musculoskeletal Pain Syndrome in Pediatric Patients

U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07249931) titled 'Efficacy and Safety of Nerivio for the Management of Amplified Musculoskeletal Pain Syndrome in Pediatric Patients' on Nov. 06.

Brief Summary: The goal of this trial is to learn how the Nerivio(R) device works to treat Amplified Musculoskeletal Pain Syndrome (AMPS) in children ages 8-18. Nerivio(R) is a wearable device that activates specific nerves in the upper arm. This causes a response from the brain that has been helpful for people who experience migrane headaches. The main questions this study aims to answer are:

* How well does the Nerivio(R) device help in reducing pain in children with AMPS?

* Does the use of the Nerivio(...